CIFoundry
Back to Catalog
Cardiology
FDA 510(k) cleared (first AI ECG clearance, 2017); CE marked. Philips resting-ECG and wearable AI remain investigational in US

Philips Cardiologs Holter Platform

Save to shortlist
Philips (Cardiologs)2017

Last reviewed Nov 9, 2026 against the sources listed on this page · How we review

At a glance

Cardiologs is deep-learning software from Philips that analyzes ambulatory (Holter) ECG recordings and flags more than 20 types of rhythm events, including atrial fibrillation, AV block and…

FDA:
510(k) K250569 +1 more
Epic:
Not on record
Named users:
3 named in public reports
Published study:
Not on record

Description

Cardiologs is deep-learning software from Philips that analyzes ambulatory (Holter) ECG recordings and flags more than 20 types of rhythm events, including atrial fibrillation, AV block and ventricular tachycardia. It works with recordings from many device makers and is designed to cut review time for cardiology teams.

ECGHolterArrhythmia detection

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is Philips Cardiologs Holter Platform FDA cleared?
The public FDA database has 2 records that our team matched to Philips Cardiologs Holter Platform. The most recent is 510(k) K250569 (Cardiologs Holter Platform), decided Aug 2025. Check that the cleared use matches how you plan to use it.FDA record K250569
Which health systems use Philips Cardiologs Holter Platform?
Linked public reports name 3 organizations: University Hospitals Sussex NHS FT, Vall d'Hebron University Hospital and Martini Hospital Groningen. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.University Hospitals Sussex NHS FT (Philips) Vall d'Hebron University Hospital (Philips) Martini Hospital Groningen (Philips)

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

3 organizations

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

Last checked Nov 9, 2026. Spot an error? Let us know through the discussion below.

Get weekly updates for Cardiology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

  • K250569 · 510(k) · Aug 2025
    Cardiologs Holter Platform
  • K241890 · 510(k) · Mar 2025
    Philips Holter Analysis System

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (5)Show

Dated events on this listing's public record, newest first.

  1. Oct 31, 2026

    Added to CIFoundry

  2. Aug 6, 2025

    FDA 510(k) K250569 decision datesource

  3. Mar 21, 2025

    FDA 510(k) K241890 decision datesource

  4. May 22, 2024

    News report names Vall d'Hebron University Hospital as a user (Philips)source

  5. Sep 7, 2023

    News report names Martini Hospital Groningen as a user (Philips)source

Developer

Philips (Cardiologs)

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.